US 9,808,207 B2
Detecting, assessing and managing a risk of death in epilepsy
Ivan Osorio, Leawood, KS (US)
Assigned to Flint Hills Scientific, L.L.C., Lawrence, KS (US)
Filed by FLINT HILLS SCIENTIFIC, L.L.C., Lawrence, KS (US)
Filed on Oct. 25, 2016, as Appl. No. 15/333,802.
Application 15/333,802 is a continuation of application No. 14/026,998, filed on Sep. 13, 2013, granted, now 9,504,390.
Application 14/026,998 is a continuation of application No. 13/091,033, filed on Apr. 20, 2011, granted, now 8,562,524, issued on Oct. 22, 2013.
Application 13/091,033 is a continuation in part of application No. 13/040,996, filed on Mar. 4, 2011, granted, now 8,562,523, issued on Oct. 22, 2013.
Prior Publication US 2017/0035368 A1, Feb. 9, 2017
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 5/00 (2006.01); A61N 1/365 (2006.01); A61N 1/36 (2006.01); A61N 1/39 (2006.01); A61B 5/16 (2006.01); A61B 5/0452 (2006.01); A61B 5/0205 (2006.01); A61B 5/08 (2006.01); A61B 5/021 (2006.01); A61B 5/0245 (2006.01); A61B 5/11 (2006.01); G06F 19/00 (2011.01); A61F 7/00 (2006.01); A61M 5/172 (2006.01); A61N 1/372 (2006.01)
CPC A61B 5/746 (2013.01) [A61B 5/021 (2013.01); A61B 5/0205 (2013.01); A61B 5/02455 (2013.01); A61B 5/0452 (2013.01); A61B 5/0826 (2013.01); A61B 5/1118 (2013.01); A61B 5/162 (2013.01); A61B 5/4094 (2013.01); A61B 5/7275 (2013.01); A61F 7/00 (2013.01); A61M 5/1723 (2013.01); A61N 1/36064 (2013.01); A61N 1/36139 (2013.01); A61N 1/36514 (2013.01); A61N 1/36585 (2013.01); A61N 1/3987 (2013.01); G06F 19/3431 (2013.01); A61B 5/02055 (2013.01); A61B 5/4836 (2013.01); A61B 5/4839 (2013.01); A61M 2230/06 (2013.01); A61M 2230/20 (2013.01); A61M 2230/201 (2013.01); A61M 2230/208 (2013.01); A61M 2230/30 (2013.01); A61M 2230/42 (2013.01); A61M 2230/63 (2013.01); A61N 1/36142 (2013.01); A61N 1/37247 (2013.01); A61N 1/37258 (2013.01)] 24 Claims
OG exemplary drawing
 
1. A method for determining and responding in real-time to an increased risk of death relating to a patient with epilepsy, comprising:
receiving cardiac data into a medical device;
determining, at least one cardiac index based upon said cardiac data;
determining whether said cardiac index is an extreme cardiac index by determining whether said cardiac index is below a low cardiac threshold value or above a high cardiac threshold value;
determining, using the medical device, the increased risk of death associated with epilepsy in response to a determination that said cardiac index is the extreme cardiac index; and
performing a responsive action based upon an occurrence of the increased risk of death, said responsive action comprises at least one of issuing automatically a warning; providing a therapy, or logging automatically information related to the increased risk of death.